Delta 9 Cannabis Inc (CVE:NINE – Get Rating) Director Hugh Housser Aird sold 80,000 shares of the business's stock in a transaction dated Friday, August 26th. The shares were sold at an average price of C$0.16, for a total value of C$13,112.00. Following the completion of the transaction, the director now owns 167,500 shares in the company, valued at approximately C$27,453.25.
Hugh Housser Aird also recently made the following trade(s):
Get Delta 9 Cannabis alerts:- On Monday, August 22nd, Hugh Housser Aird sold 45,000 shares of Delta 9 Cannabis stock. The shares were sold at an average price of C$0.19, for a total value of C$8,338.50.
Delta 9 Cannabis Price Performance
Delta 9 Cannabis stock opened at C$1.03 on Friday. The company has a debt-to-equity ratio of 33.00, a current ratio of 4.44 and a quick ratio of 2.04. The business has a 50 day simple moving average of C$1.03 and a 200-day simple moving average of C$1.03. Delta 9 Cannabis Inc has a 12 month low of C$0.92 and a 12 month high of C$2.35. The stock has a market capitalization of C$89.36 million and a PE ratio of 19.07.
Delta 9 Cannabis Company Profile
(Get Rating)
Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.
Recommended Stories
- Could Nike Stock be Oversold, but Still Overvalued?
- Is Alcoa A Buy After Strong Q2 Results And More Share Buybacks?
- Will Royal Caribbean's Broadband Partnership Drive Revenue?
- Chip Gear Maker Entegris Has Potential, But Is It Buyable Now?
- DocuSign Has Important Issues to Address When it Reports Earnings
Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.